Literature DB >> 18304959

Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps.

Martha J Shrubsole1, Huiyun Wu, Reid M Ness, Yu Shyr, Walter E Smalley, Wei Zheng.   

Abstract

The authors evaluated alcohol drinking and cigarette smoking in relation to risk of colorectal polyps in a Nashville, Tennessee, colonoscopy-based case-control study. In 2003-2005, cases with adenomatous polyps only (n = 639), hyperplastic polyps only (n = 294), and both types of polyps (n = 235) were compared with 1,773 polyp-free controls. Unordered polytomous logistic regression was used to calculate adjusted odds ratios and 95% confidence intervals. Consumption of at least five alcoholic drinks per week was not strongly associated with development of polyps. Odds ratios for all polyp types were increased for dose, duration, and pack-years of cigarette smoking and were stronger for hyperplastic polyps than for adenoma. Compared with never smoking, dose-response relations were particularly strong for current smoking and duration; for > or =35 years of smoking, odds ratios were 1.9 (95% confidence interval (CI): 1.4, 2.5) for adenomatous polyps only, 5.0 (95% CI: 3.3, 7.3) for hyperplastic polyps only, and 6.9 (95% CI: 4.4, 11.1) for both types of polyps. Compared with current smoking, time since cessation was associated with substantially reduced odds; for > or =20 years since quitting, odds ratios were 0.4 (95% CI: 0.3, 0.6) for adenoma only, 0.2 (95% CI: 0.1, 0.3) for hyperplastic polyps only, and 0.2 (95% CI: 0.2, 0.4) for both polyp types. These findings support the adverse role of cigarette smoking in colorectal tumorigenesis and suggest that quitting smoking may substantially reduce the risk of colorectal polyps.

Entities:  

Mesh:

Year:  2008        PMID: 18304959     DOI: 10.1093/aje/kwm400

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  61 in total

1.  Urinary prostaglandin E2 metabolite and risk for colorectal adenoma.

Authors:  Martha J Shrubsole; Qiuyin Cai; Wanqing Wen; Ginger Milne; Walter E Smalley; Zhi Chen; Reid M Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-13

2.  Dietary intake of PUFAs and colorectal polyp risk.

Authors:  Harvey J Murff; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Qi Dai; Ginger L Milne; Reid M Ness; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2012-01-25       Impact factor: 7.045

3.  Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas.

Authors:  Xiaosheng He; Kana Wu; Shuji Ogino; Edward L Giovannucci; Andrew T Chan; Mingyang Song
Journal:  Gastroenterology       Date:  2018-04-24       Impact factor: 22.682

4.  Smoking and red blood cell phospholipid membrane fatty acids.

Authors:  H J Murff; H A Tindle; M J Shrubsole; Q Cai; W Smalley; G L Milne; L L Swift; R M Ness; W Zheng
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-08-16       Impact factor: 4.006

5.  No evidence for human papillomavirus in the etiology of colorectal polyps.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Denise A Galloway; Margaret M Madeleine; Michelle A Wurscher; Joseph J Carter; Karen W Makar; John D Potter; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-04       Impact factor: 4.254

6.  The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Authors:  Kristin Wallace; Maria V Grau; Dennis Ahnen; Dale C Snover; Douglas J Robertson; Daus Mahnke; Jiang Gui; Elizabeth L Barry; Robert W Summers; Gail McKeown-Eyssen; Robert W Haile; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

7.  Plasma lipid levels and colorectal adenoma risk.

Authors:  John-Anthony Coppola; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Qi Dai; Reid M Ness; Sergio Fazio; Wei Zheng; Harvey J Murff
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

8.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

9.  Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study.

Authors:  Daniel D Buchanan; Kevin Sweet; Musa Drini; Mark A Jenkins; Aung Ko Win; Michael Gattas; Michael D Walsh; Mark Clendenning; Diane McKeone; Rhiannon Walters; Aedan Roberts; Alasdair Young; Heather Hampel; John L Hopper; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry Phillips; Graeme P Young; Elizabeth Chow; Susan Parry; Sonja Woodall; Kathy Tucker; Amanda Muir; Michael Field; Sian Greening; Steven Gallinger; Jane Green; Michael O Woods; Renee Spaetgens; Albert de la Chapelle; Finlay Macrae; Neal I Walker; Jeremy R Jass; Joanne P Young
Journal:  Int J Colorectal Dis       Date:  2010-03-06       Impact factor: 2.571

10.  Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics.

Authors:  Daniel D Buchanan; Kevin Sweet; Musa Drini; Mark A Jenkins; Aung Ko Win; Dallas R English; Michael D Walsh; Mark Clendenning; Diane M McKeone; Rhiannon J Walters; Aedan Roberts; Sally-Ann Pearson; Erika Pavluk; John L Hopper; Michael R Gattas; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry D Phillips; Sonja Woodall; Julie Arnold; Kathy Tucker; Amanda Muir; Michael Field; Sian Greening; Steven Gallinger; Renee Perrier; John A Baron; John D Potter; Robert Haile; Wendy Frankel; Albert de la Chapelle; Finlay Macrae; Christophe Rosty; Neal I Walker; Susan Parry; Joanne P Young
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.